Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Intratumoral Localization of Aromatase and Interaction between Stromal and Parenchymal Cells in the Non–Small Cell Lung Carcinoma Microenvironment

Yasuhiro Miki, Takashi Suzuki, Keiko Abe, Satoshi Suzuki, Hiromichi Niikawa, Shinya Iida, Shuko Hata, Jun-ichi Akahira, Kazushige Mori, Dean B. Evans, Takashi Kondo, Hisafumi Yamada-Okabe, Hironobu Sasano

Cancer Res (2010) 70 (16): 6659–6669.

https://doi.org/10.1158/0008-5472.CAN-09-4653

Published: 14 August 2010

View articletitled, Intratumoral Localization of Aromatase and Interaction between Stromal and Parenchymal Cells in the Non–Small Cell Lung Carcinoma Microenvironment

Includes: Supplementary data

Journal Articles

Abstract 1660: The antitumor action of ASA404 (vadimezan; DMXAA); potential involvement of vascular endothelial growth factor (VEGF)

Bruce C. Baguley, Xiaobin Zhan, Graeme J. Finlay, William R. Wilson, Jacqueline Ross, Dean B. Evans, Stephen B. Fox, Sarah P. Gunningham, Margaret J. Currie

Cancer Res (2010) 70 (8_Supplement): 1660.

https://doi.org/10.1158/1538-7445.AM10-1660

Published: 15 April 2010

View articletitled, Abstract 1660: The antitumor action of ASA404 (vadimezan; DMXAA); potential involvement of vascular endothelial growth factor (VEGF)

Journal Articles

Abstract 3859: Evaluation of addition of the tumor-vascular disrupting agent ASA404 (vadimezan) to paclitaxel and carboplatin and the influence of subsequent ASA404 maintenance therapy using a human NSCLC xenograft model

Dean B. Evans, Robert Cozens

Cancer Res (2010) 70 (8_Supplement): 3859.

https://doi.org/10.1158/1538-7445.AM10-3859

Published: 15 April 2010

View articletitled, Abstract 3859: Evaluation of addition of the tumor-vascular disrupting agent ASA404 (vadimezan) to paclitaxel and carboplatin and the influence of subsequent ASA404 maintenance therapy using a human NSCLC xenograft model

Journal Articles

Abstract 4443: Molecular mechanistic study of ASA404 (vadimezan)-induced endothelial cell death

Alan Huang, Yan Chen, Xiaoyan Li, Helen He, Margaret McLaughlin, Rebecca Mosher, Colleen Conway, Brant Firestone, Frank Cook, Bailin Zhang, Bruce C. Baguley, Dean B. Evans, Robert Schlegel

Cancer Res (2010) 70 (8_Supplement): 4443.

https://doi.org/10.1158/1538-7445.AM10-4443

Published: 15 April 2010

View articletitled, Abstract 4443: Molecular mechanistic study of ASA404 (vadimezan)-induced endothelial cell death

Journal Articles

The Vascular Endothelial Growth Factor Receptor Inhibitor PTK787/ZK222584 Inhibits Aromatase

Susana Banerjee, Marketa Zvelebil, Pascal Furet, Ursula Mueller-Vieira, Dean B. Evans, Mitch Dowsett, Lesley-Ann Martin

Cancer Res (2009) 69 (11): 4716–4723.

https://doi.org/10.1158/0008-5472.CAN-08-4711

Published: 01 June 2009

View articletitled, The Vascular Endothelial Growth Factor Receptor Inhibitor PTK787/ZK222584 Inhibits Aromatase

Includes: Supplementary data

Journal Articles

Steroid Sulfatase and Estrogen Sulfotransferase in Colon Carcinoma: Regulators of Intratumoral Estrogen Concentrations and Potent Prognostic Factors

Ryuichiro Sato, Takashi Suzuki, Yu Katayose, Koh Miura, Kenichi Shiiba, Hiroo Tateno, Yasuhiro Miki, Junichi Akahira, Yukiko Kamogawa, Shuji Nagasaki, Kuniharu Yamamoto, Takayuki Ii, Shinichi Egawa, Dean B. Evans, Michiaki Unno, Hironobu Sasano

Cancer Res (2009) 69 (3): 914–922.

https://doi.org/10.1158/0008-5472.CAN-08-0906

Published: 29 January 2009

View articletitled, Steroid Sulfatase and Estrogen Sulfotransferase in Colon Carcinoma: Regulators of Intratumoral Estrogen Concentrations and Potent Prognostic Factors

Includes: Supplementary data

Journal Articles

Hormonal Markers in Breast Cancer: Coexpression, Relationship with Pathologic Characteristics, and Risk Factor Associations in a Population-Based Study

Xiaohong R. Yang, Ruth M. Pfeiffer, Montserrat Garcia-Closas, David L. Rimm, Jolanta Lissowska, Louise A. Brinton, Beata Peplonska, Stephen M. Hewitt, Richard W. Cartun, Daniza Mandich, Hironobu Sasano, Dean B. Evans, Thomas R. Sutter, Mark E. Sherman

Cancer Res (2007) 67 (21): 10608–10617.

https://doi.org/10.1158/0008-5472.CAN-07-2142

Published: 01 November 2007

View articletitled, Hormonal Markers in Breast Cancer: Coexpression, Relationship with Pathologic Characteristics, and Risk Factor Associations in a Population-Based Study

Journal Articles

Aromatase Localization in Human Breast Cancer Tissues: Possible Interactions between Intratumoral Stromal and Parenchymal Cells

Yasuhiro Miki, Takashi Suzuki, Chika Tazawa, Yuri Yamaguchi, Kunio Kitada, Seijiro Honma, Takuya Moriya, Hisashi Hirakawa, Dean B. Evans, Shin-ichi Hayashi, Noriaki Ohuchi, Hironobu Sasano

Cancer Res (2007) 67 (8): 3945–3954.

https://doi.org/10.1158/0008-5472.CAN-06-3105

Published: 17 April 2007

View articletitled, Aromatase Localization in Human Breast Cancer Tissues: Possible Interactions between Intratumoral Stromal and Parenchymal Cells

Journal Articles

Elevated serum levels of TIMP-1 and HER-2/neu in metastatic breast cancer patients (MBC) may be valuable in guiding targeted therapies

Peter J. Hamer, Walter P. Carney, Victor K. Gaur, Kim Leitzel, Laurence Demers, Suhail M. Ali, Dean B. Evans, Hilary A. Chaudri-Ross, Allan Lipton

Cancer Res (2006) 66 (8_Supplement): 842.

Published: 15 April 2006

View articletitled, Elevated serum levels of TIMP-1 and HER-2/neu in metastatic breast cancer patients (MBC) may be valuable in guiding targeted therapies

Journal Articles

Combining the receptor tyrosine kinase inhibitor AEE788 with tamoxifen or letrozole enhances growth inhibition of hormone-dependent human breast cancer cells

Astrid Hauge Evans, Dean B. Evans, Mitch Dowsett, Lesley-Ann Martin

Cancer Res (2005) 65 (9_Supplement): 803.

Published: 01 May 2005

View articletitled, Combining the receptor tyrosine kinase inhibitor AEE788 with tamoxifen or letrozole enhances growth inhibition of hormone-dependent human breast cancer cells

Journal Articles

The mTOR pathway in estrogen response: A potential for combining the rapamycin derivative RAD001 with the aromatase inhibitor Letrozole (Femara®) in breast carcinoma

Joëlle Rudloff, Anne Boulay, Sabine Zumstein-Mecker, Dean B. Evans, Terence O’Reilly, Heidi A. Lane

Cancer Res (2004) 64 (7_Supplement): 1298.

Published: 01 April 2004

View articletitled, The mTOR pathway in estrogen response: A potential for combining the rapamycin derivative RAD001 with the aromatase inhibitor Letrozole (Femara®) in breast carcinoma

Journal Articles

Letrozole Inhibits Tumor Proliferation More Effectively than Tamoxifen Independent of HER1/2 Expression Status

Matthew J. Ellis, Andrew Coop, Baljit Singh, Yu Tao, Antonio Llombart-Cussac, Fritz Jänicke, Louis Mauriac, Erhard Quebe-Fehling, Hilary A. Chaudri-Ross, Dean B. Evans, William R. Miller

Cancer Res (2003) 63 (19): 6523–6531.

Published: 14 October 2003

View articletitled, Letrozole Inhibits Tumor Proliferation More Effectively than Tamoxifen Independent of HER1/2 Expression Status

Journal Articles

The Osteoclast-associated Protease Cathepsin K Is Expressed in Human Breast Carcinoma

Amanda J. Littlewood-Evans, Graeme Bilbe, Wayne B. Bowler, David Farley, Brenda Wlodarski, Toshio Kokubo, Tetsuya Inaoka, John Sloane, Dean B. Evans, James A. Gallagher

Cancer Res (1997) 57 (23): 5386–5390.

Published: 01 December 1997

View articletitled, The Osteoclast-associated Protease Cathepsin K Is Expressed in Human Breast Carcinoma

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Intratumoral Localization of Aromatase and Interaction between Stromal and Parenchymal Cells in the Non–Small Cell Lung Carcinoma Microenvironment

Abstract 1660: The antitumor action of ASA404 (vadimezan; DMXAA); potential involvement of vascular endothelial growth factor (VEGF)

Abstract 3859: Evaluation of addition of the tumor-vascular disrupting agent ASA404 (vadimezan) to paclitaxel and carboplatin and the influence of subsequent ASA404 maintenance therapy using a human NSCLC xenograft model

Abstract 4443: Molecular mechanistic study of ASA404 (vadimezan)-induced endothelial cell death

The Vascular Endothelial Growth Factor Receptor Inhibitor PTK787/ZK222584 Inhibits Aromatase

Steroid Sulfatase and Estrogen Sulfotransferase in Colon Carcinoma: Regulators of Intratumoral Estrogen Concentrations and Potent Prognostic Factors

Hormonal Markers in Breast Cancer: Coexpression, Relationship with Pathologic Characteristics, and Risk Factor Associations in a Population-Based Study

Aromatase Localization in Human Breast Cancer Tissues: Possible Interactions between Intratumoral Stromal and Parenchymal Cells

Elevated serum levels of TIMP-1 and HER-2/neu in metastatic breast cancer patients (MBC) may be valuable in guiding targeted therapies

Combining the receptor tyrosine kinase inhibitor AEE788 with tamoxifen or letrozole enhances growth inhibition of hormone-dependent human breast cancer cells

The mTOR pathway in estrogen response: A potential for combining the rapamycin derivative RAD001 with the aromatase inhibitor Letrozole (Femara®) in breast carcinoma

Letrozole Inhibits Tumor Proliferation More Effectively than Tamoxifen Independent of HER1/2 Expression Status

The Osteoclast-associated Protease Cathepsin K Is Expressed in Human Breast Carcinoma

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only